In addition, and to examine a therapeutic potential of rHDL particles in vivo, we compared Panc02 tumor growth in WT mice, Apoa1 KO mice receiving PBS, and Apoa1 KO mice receiving intravenous injections of rHDL (0.2 mg per injection every other day). The gene discussed is APOA1; the disease is neoplasm.